Introduction: This study clarifies medical care and outcomes for patients hospitalized with COVID-19 and evaluates SARS-CoV-2 infection risk in healthcare professionals, to contribute to appropriate responses in future outbreaks of emerging infectious diseases.
Methods: In total, 585 patients with COVID-19 were classified by disease severity, and laboratory test findings and treatments were examined. Serum IgG antibodies against SARS-CoV-2 spike protein (IgG S antibodies) and those against nucleocapsid protein (IgG N antibodies) were measured in 21 expert respiratory physicians.
Results: Multiple comparison analysis showed significant differences in body mass index (BMI), white blood cell count (WBC), neutrophil count (Neut), lymphocyte count, lactate dehydrogenase (LDH), C-reactive protein, hemoglobin A1c, ferritin, Krebs von den Lungen-6, and D-dimer depending on disease severity. There were significant differences in BMI, WBC, Neut, LDH, and D-dimer between the severe and critical groups. Times from onset to admission and to start of treatment both increased according to severity and were significantly longer in the critical group. Among critical patients requiring ventilation, times from onset to admission, to start of remdesivir, and to start of systemic steroid therapy were significantly longer in those who died. Serum IgG S and IgG N antibody measurements in the 21 respiratory physicians did not indicate direct SARS-CoV-2 transmission from patients.
Conclusion: We identified laboratory test items predicting severe and critical COVID-19 and demonstrated the importance of prompt administration of antiviral and anti-inflammatory agents after symptom onset. SARS-CoV-2 transmission to medical professionals may be prevented by adherence to wearing personal protective equipment.
抄録全体を表示